Aytu BioPharma (NASDAQ:AYTU) Announces Earnings Results, Misses Estimates By $0.37 EPS
Aytu BioPharma (NASDAQ:AYTU – Get Free Report) announced its earnings results on Thursday. The company reported ($0.82) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.45) by ($0.37), Zacks reports. Aytu BioPharma had a negative net margin of 14.60% and a negative return on equity of 31.31%. The business had revenue of […]
More Stories
SAB Biotherapeutics, Inc. (NASDAQ:SABS) Sees Large Decrease in Short Interest
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Free Report) was the target of a significant decrease in short interest in the...
Valmet Oyj (OTCMKTS:VOYJF) Sees Large Decrease in Short Interest
Valmet Oyj (OTCMKTS:VOYJF – Get Free Report) was the recipient of a significant drop in short interest during the month...
Ubisoft Entertainment SA (OTCMKTS:UBSFY) Sees Significant Decrease in Short Interest
Ubisoft Entertainment SA (OTCMKTS:UBSFY – Get Free Report) was the target of a large drop in short interest in the...
SecureWorks Corp. (NASDAQ:SCWX) Short Interest Down 33.4% in October
SecureWorks Corp. (NASDAQ:SCWX – Get Free Report) was the target of a significant drop in short interest in October. As...
SecureWorks Corp. (NASDAQ:SCWX) Short Interest Down 33.4% in October
SecureWorks Corp. (NASDAQ:SCWX – Get Free Report) was the target of a significant drop in short interest in October. As...
SLM Co. (NASDAQ:SLMBP) Short Interest Update
SLM Co. (NASDAQ:SLMBP – Get Free Report) was the recipient of a large drop in short interest in October. As...